Sequencing and analysis
The enriched libraries were sequenced using 101 bp paired-end mode on an Illumina HiSeq 2500 sequencer. Sequenced samples (consisting of FASTQ files) were aligned using the BWA-MEM aligner (BaseSpace Labs, Illumina, https://basespace.illumina.com) to a human reference genome version 19, using following tools: BWA version 0.7.13 (https://github.com/lh3/bwa), SAMtools version 1.3
(https://github.com/samtools/samtools), Picard version 2.1.1
(https://github.com/broadinstitute/picard). Aligned reads were recalibrated, sorted, marked for read duplication, and realigned near insertion/deletion (indels) using Genome Analysis ToolKit (GATK 3.7-0, http://www.broadinstitute.otg.gatk). Subsequent variant calling and filtrations were performed using generated from bam files (without removal of duplicate reads, as recommended for pooled sequencing) using Galaxy platform (https://usegalaxy.org). Firstly, bam files were sliced using the Samtools (Galaxy version 2) by the genomic regions containing exonic targets. Secondly, the genetic variants in the genomic targets were annotated using MPileup call variants (Galaxy Version 2.1.1) routine. The resulted pileup files were processed by VarScan2 software (Galaxy version version 0.1) for the final detection of variants. After final reads assembly by VarScan software and passing quality filters the subsequent screening of sequenced exons (in vcf format) was performed against dbSNP138 using wAnnovar software [14, 15] . The output files (one for each pool) from previous step was annotated by the dbNSFP version 3.2a software (https://sites.google.com/site/jpopgen/dbNSFP). The dbNSFP is an integrated database of functional annotations from multiple sources for the comprehensive collection of human non-synonymous single variants polymorphisms (nsSNVs). Its current version includes a total of 83,422,341 nsSNVs and splice site SNVs (ssSNVs). It compiles prediction scores from 17 prediction algorithms. In addition, each file was analyzed by the companion dbscSNV database, which includes all potential human SNV within splicing consensus regions (−3 to +8 at the 5' splice site and −12 to +2 at the 3' splice site), i.e. splicing consensus regions (scSNVs), and predictions for their potential of altering splicing.
Quality control and prioritization
Pooled sequencing, the initial quality analysis allow only variants with the quality read depth of bases with Phred score ≥30 and average per-pool sample depth of bases with Phred score ≥30 were subjected for further analysis. Low variant counts per pool (<12)
were also filtered out. All variants were then additionally filtered using a Forward/Reverse stand balance between 10-90% (strand bias). Because of the study focus on the low frequency variants (MAF <5%) all variants with MAF ≥5% were removed from further analysis.
Verification of selected variants by individual genotyping
Individual genotyping for selected markers in individual DNA samples was performed using a custom Sequenom iPLEX assay in conjunction with the Mass ARRAY platform (Sequenom Inc., La Jolla, CA, USA) Panels of SNP markers were designed using Sequenom Assay Design 3.2 software (Sequenom Inc., La Jolla, CA, USA), similar to previously described methodology from our laboratory [9, 16, 17] . 
